Nothing more to see!I had mixed feelings about approval. Although I'm glad for the patients stockholders screwed again. They just gave their only source of revenue away for peanuts. Why? The only thing left now is refinancing, as they purposely got rid of the revenue stream.
Kedrion would get 30% of a voucher so let's say 30 million. They paid 5 million for Ryplasim platform that cost hundreds of millions to develop. The whole PPPS was great innovative technology to prepare to surpass the old Cohn process, they threw it away. This makes no sense. Why?
They put their most advanced trials with great previous results on the shelf. Why?
Sure seems like they want to go private.